Literature DB >> 9305318

Practice advisory on the treatment of amyotrophic lateral sclerosis with riluzole: report of the Quality Standards Subcommittee of the American Academy of Neurology.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9305318     DOI： 10.1212/wnl.49.3.657

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  8 in total

1.  Riluzole treatment in advanced ALS.

Authors:  Gian Domenico Borasio
Journal:  J Neurol       Date:  2002-05       Impact factor: 4.849

2.  Management of symptoms in amyotrophic lateral sclerosis.

Authors:  Lisa S Thibodeaux; Amparo Gutierrez
Journal:  Curr Treat Options Neurol       Date:  2008-03       Impact factor: 3.598

Review 3.  Amyotrophic lateral sclerosis: pathophysiology, diagnosis and management.

Authors:  Paul H Gordon
Journal:  CNS Drugs       Date:  2011-01       Impact factor: 5.749

4.  Cost effectiveness of riluzole in amyotrophic lateral sclerosis. Italian Cooperative Group for the Study of Meta-Analysis and the Osservatorio SIFO sui Farmaci.

Authors:  A Messori; S Trippoli; P Becagli; G Zaccara
Journal:  Pharmacoeconomics       Date:  1999-08       Impact factor: 4.981

5.  Progression of white matter degeneration in amyotrophic lateral sclerosis: A diffusion tensor imaging study.

Authors:  Yu Zhang; Norbert Schuff; Susan C Woolley; Gloria C Chiang; Lauren Boreta; Joel Laxamana; Jonathan S Katz; Michael W Weiner
Journal:  Amyotroph Lateral Scler       Date:  2011-07-11

Review 6.  Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).

Authors:  Robert G Miller; J D Mitchell; Dan H Moore
Journal:  Cochrane Database Syst Rev       Date:  2012-03-14

Review 7.  Exercise and amyotrophic lateral sclerosis.

Authors:  J P Lopes de Almeida; R Silvestre; A C Pinto; M de Carvalho
Journal:  Neurol Sci       Date:  2012-01-07       Impact factor: 3.307

Review 8.  Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  R G Miller; C E Jackson; E J Kasarskis; J D England; D Forshew; W Johnston; S Kalra; J S Katz; H Mitsumoto; J Rosenfeld; C Shoesmith; M J Strong; S C Woolley
Journal:  Neurology       Date:  2009-10-13       Impact factor: 9.910
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.